Object: Pediatric low-grade gliomas (LGGs) are the largest group of central nervous system neoplasms in children. Although these tumors are generally benign, 5 to 10% of patients with pediatric LGGs present with leptomeningeal dissemination. The genetic and biological nature of these tumors is poorly understood. The authors looked for certain molecular abnormalities that may differentiate disseminated gliomas from the other pediatric LGGs.
Methods: Comparative genomic hybridization (CGH) was applied to 18 pediatric LGGs. Six cases featuring disseminated pediatric LGGs were compared with 12 control cases involving nondisseminated pediatric LGGs. Fluorescence in situ hybridization (FISH) analysis and immunohistochemical analysis were used to highlight further specific genetic targets. The CGH revealed multiple chromosomal abnormalities in five of six cases with disseminated gliomas and in six of 12 control cases. No correlation was found between the number of chromosomal abnormalities and dissemination status. Amplification of chromosome 7 was noted in four of six cases with disseminated gliomas as opposed to one of 12 control cases (p = 0.02). The FISH analysis revealed epidermal growth factor receptor (EGFR) amplification in one case negative to chromosome 7 amplification by CGH, raising the amplification cases to five of six (p = 0.0038). Immunohistochemical analysis for EGFR was positive in six of six cases and in two of 12 control cases (p = 0.0015). At the end of a mean follow-up period of 7.2 years, all patients with disseminated gliomas are alive with variable but slow disease progression.
Conclusions: The high rate of EGFR gene amplification and protein expression in disseminated pediatric LGGs is intriguing and may have implications for our understanding of the role of EGFR in glioma genesis. Targeted therapies may be available for these children. Larger-scale studies are needed to establish further these findings.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3171/ped.2005.103.4.0357 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Human single cell RNA-sequencing reveals a targetable CD8 exhausted T cell population that maintains mouse low-grade glioma growth.
Nat Commun
November 2024
Department of Neurology, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Article Synopsis
- * Research using single-cell RNA sequencing shows that pediatric low-grade gliomas (LGGs) have more exhausted CD8 T cells compared to high-grade gliomas in both children and adults.
- * Preclinical studies reveal that in LGGs, exhausted CD8 T cells are mainly found in tumor tissue and play a role in promoting tumor growth, and ICI treatments can reduce tumor proliferation through specific cytokine suppression rather than direct T cell killing.
Lactobacillus rhamnosus modulates murine neonatal gut microbiota and inflammation caused by pathogenic Escherichia coli.
BMC Microbiol
November 2024
Department of Pediatrics, Division of Infectious Diseases, Children's Mercy Kansas City, Kansas City, MO, USA.
Background: Pathogenic Escherichia coli strains produce neonatal septicemia after colonizing the neonatal gut. While the probiotic Lactobacillus rhamnosus GG (LGG) effectively reduces neonatal sepsis, LGG's effects on the neonatal intestinal microbiota alterations and inflammation triggered by E. coli are incompletely understood.
View Article and Find Full Text PDFMechanical properties of pediatric low-grade gliomas in children with and without neurofibromatosis type 1.
Neuroradiology
December 2024
Department of Radiology, Nemours Children's Hospital, Wilmington, DE, USA.
Introduction: Prognoses for pediatric brain tumors are suboptimal, as even in low-grade tumors, management techniques can lead to damage in the developing brain. Therefore, advanced neuroimaging methods are critical for developing optimal management plans and improving patient care. Magnetic resonance elastography (MRE) has allowed for the characterization of adult gliomas by their mechanical properties, which are uniquely sensitive to the complex interplay of cellularity, vasculature, and interstitium.
View Article and Find Full Text PDFBRAF/MEK inhibitors use for pediatric gliomas; real world experience from a resource-limited country.
Front Oncol
September 2024
Department of Pediatrics, King Hussein Cancer Center, Amman, Jordan.
Introduction: Most pediatric low-grade-gliomas (LGG) and some high-grade-gliomas (HGG) have alterations in the RAS/MAPK pathway. Promising high tumor response rates were achieved using BRAF/MEK inhibitors, however data on their use in low-middle-income-countries (LMICs) are limited.
Methods: We retrospectively reviewed our Jordanian experience of using compassionate BRAF/MEK inhibitors in treating children with gliomas.
Unlocking delays: revealing barriers to early diagnosis of childhood central nervous system tumors in an upper-middle-income country.
Childs Nerv Syst
November 2024
Department of Pediatrics, Federal University of Sao Paulo, Sao Paulo, Brazil.
Purpose: Childhood central nervous system (CNS) tumors tend to have a longer time interval until diagnosis than other pediatric malignancies. The aim is to describe the time to diagnosis among Brazilian pediatric patients treated at a tertiary center and explore associated factors.
Methods: Cross-sectional study; application of questionnaires to parents of children with CNS tumors during outpatient visit or inpatient care.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!